|
PMI is a positive selection system that offers scientists a novel and
efficient alternative to using antibiotic resistance and herbicide tolerance
markers in genetically modified (GM) crops. The system is being made available
by Syngenta under license. This sheet aims to answer some of your likely
questions.
Who is the PMI technology being made
available to?
Both companies and not-for-profit research institutions are invited to contact
Syngenta regarding access to the PMI system. The technology will be made
available for research-only purposes on completion of an agreement. Commercial licenses (and options to
commercial licenses) are also available.
Will PMI constructs be made available?
Syngenta will provide PMI constructs to requestors once the agreement is fully
executed. The PMI system is available in a number of constructs and
bacterial strains to suit individual requirements and to fit all currently used
transformation systems. All the applicant needs to do is inform Syngenta on
their intended use of PMI and to identify the relevant transformation
system they will be using.
Will help be made available with regard to using the
PMI system?
PMI is a positive selection system that is compatible with traditional
transformation procedures and therefore should be relatively easy to use by
those with experience in transformation. However, Syngenta will, upon request
of the recipient, provide appropriate protocols for the research, under the
confidentiality provisions of the agreement.
Are there any opportunities for collaboration on
PMI?
If there are promising results or ideas in a particular field, Syngenta would,
of course, be willing to consider potential further collaborations. Please feel
free to contact us if you have interest in a collaboration.
How do I contact Syngenta about PMI?
For inquiries about licensing or access for academic or not-for-profit
organizations, contact
For inquiries about licensing or access for commercial organizations, contact
|